Jeffrey Kindler elected as PhRMA chairman
This article was originally published in Scrip
Executive Summary
Jeffrey Kindler, chairman and chief executive officer of Pfizer, was elected board chairman of the Pharmaceutical Research and Manufacturers of America (PhRMA) at the trade association's annual meeting this week. Also elected were Sanofi-Aventis's CEO Christopher Viehbacher as chairman-elect and Dr John Lechleiter, chairman, president and CEO of Lilly, as board treasurer. Mr Kindler succeeds David Brennan, CEO and executive director of AstraZeneca, as PhRMA's chairman.